4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-027339
Chair and CEO sold 27,887 shares at an average $67.66 ($1,886,957)
- Chair and CEO acquired 6,830 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-20 | Sale : show line 1 in the form 10b5-1 | −9,489 | $66.87 | $634,529 | 325,798 | D |
| 2025-05-20 | Sale : show line 2 in the form 10b5-1 | −4,480 | $67.96 | $304,461 | 321,318 | D |
| 2025-05-20 | Sale : show line 3 in the form 10b5-1 | −7,088 | $68.49 | $485,457 | 314,230 | D |
| 2025-05-20 | Exercise or conversion : show line 4 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-05-20 | Sale : show line 5 in the form 10b5-1 | −2,863 | $66.90 | $191,535 | 237,891 | I |
| 2025-05-20 | Sale : show line 6 in the form 10b5-1 | −2,251 | $68.13 | $153,361 | 235,640 | I |
| 2025-05-20 | Sale : show line 7 in the form 10b5-1 | −1,716 | $68.54 | $117,615 | 233,924 | I |
| Open-market sales · 27,887 sh · avg $67.66 · $1,886,957 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-20 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 163,990 | I |
Loading xslF345X05/wk-form4_1747948703.xml…